Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)

3.10
Delayed Data
As of May 24
 -0.005 / -0.16%
Today’s Change
2.70
Today|||52-Week Range
4.99
-10.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization18.0K16.0K16.0K14.0K
 
 
 
 
 
 
Operating ExpensesGross Income-18.0K-16.0K-16.0K-14.0K
 
 
 
 
 
General Expenses5.1M4.8M5.8M5.5M
 
 
 
 
 
Research And Development3.0M2.8M3.9M3.6M
 
 
 
 
 
Total Operating Expenses5.1M4.8M5.8M5.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.1M-4.8M-5.8M-5.5M
 
 
 
 
 
Extraordinary Credit6.0K0.000.00--
 
 
Other Expenses21.0K42.0K49.0K50.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.1M-4.8M-5.8M-5.5M
 
 
 
 
 
Net Income-5.1M-4.8M-5.8M-5.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.0M7.3M7.5M7.8M
 
 
 
 
 
Shares To Calculate EPS Diluted4.0M7.3M7.5M7.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.27-$0.65-$0.77-$0.71
 
 
 
 
 
EPS Diluted-$1.27-$0.65-$0.77-$0.71